Depleting luminal cysteine with engineered bacteroides vulgatus alleviates experimental colitis by suppressing Th17 differentiation through an ATF6-dependent mechanism
Jianghao Wang, Zhe-Xian Tian, Shanwen Chen, Grace Y. Chen, Yi-Ping Wang, Pengyuan Wang · 2026
Read Depleting luminal cysteine with engineered bacteroides vulgatus alleviates experimental colitis by suppressing Th17 differentiation through an ATF6-dependent mechanism by Jianghao Wang, Zhe-Xian Tian, Shanwen Chen, Grace Y. Chen, Yi-Ping Wang, Pengyuan Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13546354.txt.
Description
Jianghao Wang and co-authors engineer a gut bacterium to ease colitis in mice in a 2026 study. Ulcerative colitis is a long-term bowel disease driven by faulty immune response, in part by a T cell type that fuels swelling. Standard probiotics lack a precise way to target that drive.
The team gave a common gut species a gene that makes it soak up cysteine, an amino acid, from the gut. The altered strain settled well and beat the natural strain at taking up cysteine. In mouse colitis it eased signs, cut swelling signals, and helped restore the gut wall. The path runs through a cell stress protein.
Catalog record
| CREATOR | Jianghao Wang, Zhe-Xian Tian, Shanwen Chen, Grace Y. Chen, Yi-Ping Wang, Pengyuan Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |